9528 studies found for:    chemotherapy
Show Display Options
Rank Status Study
1 Recruiting Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy
Condition: Pancreatic Cancer
Interventions: Drug: Induction chemotherapy with gemcitabine or FOLFIRINOX;   Radiation: Radiotherapy, 28 x 1.8 Gy;   Drug: Chemotherapy, gemcitabine;   Drug: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
2 Unknown  Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Peri-operative chemotherapy of ECX;   Drug: Peri-operative chemotherapy of XP
3 Unknown  Study of Neoadjuvant Chemotherapy of Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant chemotherapy;   Drug: Chemotherapy
4 Recruiting Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Interventions: Procedure: Cytoreductive Surgery (CRS);   Drug: Systemic Chemotherapy;   Other: Questionnaire;   Procedure: Hyperthermic intraperitoneal chemotherapy;   Drug: Carboplatin;   Drug: Paclitaxel
5 Completed Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
Condition: Non Small Cell Lung Cancer
Interventions: Radiation: radiation;   Other: Chemotherapy and radiotherapy;   Drug: Chemotherapy;   Other: Palliative radiotherapy and chemotherapy
6 Not yet recruiting Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer
Conditions: Colon Cancer;   Locally Advanced Malignant Neoplasm
Interventions: Other: Perioperative simplified FOLFOX-4 chemotherapy;   Other: Perioperative FOLFOX4+Cetuximab chemotherapy;   Other: Surgery followed by FOLFOX4 chemotherapy
7 Not yet recruiting The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: One cycle TPF induction chemotherapy for NPC;   Drug: Three cycles TPF induction chemotherapy for NPC
8 Recruiting Safety Study Of Anakinra Combined With Chemotherapy And Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: DC vaccination+Preop chemotherapy;   Biological: DC vaccination+Preop chemo+anakinra
9 Completed Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
Condition: Colorectal Peritoneal Carcinomatosis
Interventions: Drug: Systemic chemotherapy alone (oxaliplatin, 5-fluorouracil, isovorin);   Procedure: Cytoreductive surgery (CRS) plus postoperative intraperitoneal chemotherapy (5-fluorouracil, isovorin)
10 Withdrawn Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
Conditions: Metastatic Liver Cancer;   Secondary Liver Cancer;   Liver Neoplasm
Interventions: Device: Radiofrequency Ablation (RFA);   Drug: Chemotherapy
11 Recruiting Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study
Condition: Nasopharyngeal Carcinoma
Interventions: Device: Chrono-chemotherapy pump:Melodie;   Device: Routine intravenous drip;   Drug: induction chemotherapy;   Drug: cisplatin chrono-chemotherapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin routine-chemotherapy
12 Recruiting Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Inductive chemotherapy + concurrent cisplatin and IMRT;   Drug: Inductive chemotherapy + IMRT
13 Recruiting Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Chemotherapy;   Drug: Icotinib+chemotherapy
14 Unknown  High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Condition: Brain Tumor
Intervention: Procedure: high-dose chemotherapy and autologous stem cell rescue
15 Recruiting Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tubes Cancer;   Peritoneal Cancer
Interventions: Procedure: Secondary Cytoreductive Surgery;   Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC);   Drug: platinum-based systemic chemotherapy postoperatively
16 Recruiting Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Conditions: Non Small Cell Lung Cancer;   Breast Cancer
Interventions: Drug: YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 30μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 45μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: PEG-rhG-CSF, 100μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
17 Recruiting NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Adjuvant chemotherapy with paclitaxel and nedaplatin
18 Unknown  Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Condition: Depression
Interventions: Device: Thrymatron System IV device (CONSOLIDATION ELECTROCONVUsLIVE THERAPY) plus PHARMACOTHERAPY;   Drug: PHARMACOTHERAPY
19 Recruiting Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial
Condition: Local Advanced High Risk Nasopharyngeal Carcinoma
Interventions: Drug: IMRT combine with cisplatin concurrent chemotherapy;   Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
20 Completed Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Chemotherapy;   Drug: Genomic driven chemotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years